Komaroff AL, Zerr DM, Flamand L

Summary of the 11th International Conference on Human Herpesviruses-6A, -6B, and -7.

J Med Virol, 92 (1), p. 4-10, 2020, ISSN: 0146-6615.

Résumé | Liens:

Pope J, Rampakakis E, Vaillancourt J, Bessette L, Lazovskis J, Haraoui B, Sampalis JS

An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDs.

Rheumatology (Oxford), 2019, ISSN: 1462-0324.

Résumé | Liens:

Stafinski T, Deber R, Rhainds M, Martin J, Noseworthy T, Bryan S, Menon D

Decision-Making on New Non-Drug Health Technologies by Hospitals and Health Authorities in Canada.

Healthc Policy, 15 (1), p. 82-94, 2019, ISSN: 1715-6572.

Résumé | Liens:

Stafinski T, Deber R, Rhainds M, Martin J, Noseworthy T, Bryan S, Menon D

The Introduction of New Non-Drug Health Technologies into Canadian Healthcare Institutions: Opportunities and Challenges.

Healthc Policy, 15 (1), p. 95-106, 2019, ISSN: 1715-6572.

Résumé | Liens:

Enocsson H, Wirestam L, Dahle C, Padyukov L, Jonsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcon GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven RF, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T, Bruce IN, Wettero J, Sjowall C

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.

J Autoimmun, p. 102340, 2019, ISSN: 0896-8411.

Résumé | Liens: